AOD-9604 vs Dulaglutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (hGH), specifically the C-terminal region spanning amino acids 176-191 with an additional tyrosine at position 177. It was designed to isolate the fat-metabolizing properties of hGH without the IGF-...
Calculate AOD-9604 dose →Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...
Calculate Dulaglutide dose →| Parameter | AOD-9604 | Dulaglutide |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Phase IIb (Discontinued) | FDA Approved |
| Half-Life | ~30 minutes | ~5 days |
| Typical Dose | 300 µg | 0.75–4.5 mg |
| Frequency | Once daily (fasted) | Once weekly |
| Route | Subcutaneous / Oral | Subcutaneous (weekly) |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.